JPM vs RCUS Stock Comparison

JPM currently leads RCUS in this stock comparison, with AIQ scores of 65 vs 39. The clearest difference is quality, while RCUS has the stronger value profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 26 points
JPM
Financial Services
vs
RCUS
Healthcare
JPM
JPMorgan Chase & Co.
Leads
Price
$346
Day move
+0.98%
AIQ Score
65/100
Best edge
Quality
Sector
Financial Services
RCUS
Arcus Biosciences, Inc.
Price
$17.43
Day move
-1.91%
AIQ Score
39/100
Best edge
Value
Sector
Healthcare

What is the main difference between JPM and RCUS?

JPM leads the current stock comparison as JPMorgan Chase & Co., with the clearest separation coming from quality and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

JPMorgan Chase & Co. vs Arcus Biosciences, Inc.

Data as of Nov 15, 2026· market close· Cross-sector · Financial Services vs Healthcare· Coverage 65/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 8/10

JPM leads

JPM leads by 26 AIQ points, primarily on Quality and Risk Resilience, and the lead has widened from 15 points over 30 sessions. Wall Street currently favors RCUS on target upside.

Competitive: 4 of 6 evidence groups support JPM, its lead is widening, and its current signal state is conflicted.

Evidence agreement: 4 of 6Comparison trend: Strengthening
JPM

JPMorgan Chase & Co.

Leads
AIQ Score
65/100
AIQ Edge Score
8/10
RCUS

Arcus Biosciences, Inc.

AIQ Score
39/100
AIQ Edge Score
2/10

The Algovestiq AIQ Score currently favors JPM over RCUS, 65 versus 39 as of Nov 15, 2026. JPM's advantage is driven primarily by stronger quality and risk resilience, while RCUS holds the stronger value profile. JPM also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors RCUS. 4 of 6 covered evidence groups favor JPM today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. JPM lead: Strengthening — the AIQ differential moved from 15 to 26 points over 30 sessions.

Compare JPMorgan Chase & Co. and Arcus Biosciences, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

JPM
+138.4%
RCUS
-52.8%

Total return comparison

Growth of $10,000, distributions reinvested

JPM $23,841 · RCUS $4,722

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare JPM and RCUS against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

JPM advantage
0
RCUS advantage
  • Quality86 vs 41
    JPM +45
  • Risk Resilience87 vs 42
    JPM +45
  • Momentum70 vs 34
    JPM +36
  • Value10 vs 43
    RCUS +33

4 of 6 evidence groups favor JPM. JPM’s edge is concentrated in quality and risk resilience; RCUS keeps a meaningful value edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

JPM0 AIQ

Largest factor move: Momentum +1, not enough on its own to move the overall score.

New signals

  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.0%)
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
RCUS0 AIQ

Largest factor move: Value +2, not enough on its own to move the overall score.

New signals

  • ADX Trend Strengthening — neutral, trend, medium horizon

JPM's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — JPM and RCUS both carry a full feed there.

The central trade-off

JPM (JPMorgan Chase & Co.): the stronger current systematic profile, led by quality and risk resilience.

RCUS (Arcus Biosciences, Inc.): the counter-case, on value, valuation, analyst expectations — but at materially higher volatility, 92.2% against 27.4%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

JPM

JPM on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

JPM

JPM on combined revenue and EPS growth.

Value

RCUS

RCUS on the peer-relative Value factor, by 33 points.

Momentum

JPM

JPM on the Momentum factor, by 36 points.

Lower downside

JPM

JPM on Risk Resilience, by 45 points.

Analyst upside

RCUS

RCUS on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors JPM, analyst targets favor RCUS. That disagreement is the most useful thing on this page.

MeasureJPMRCUSNote
Implied upside to target+7.8%+161%RCUS has more room
Target dispersion+30.3%+19.8%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering2615Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

4 of 6 covered evidence groups favor JPM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreJPM65 vs 39
FundamentalsJPMon balancerevenue growth -7.6% vs -78%; EPS growth -27.6% vs -38.9%; TTM ROE 4.1% vs -35.8%; gross margin 63.2% vs 95%; operating margin 28.2% vs -4.7% — JPM takes 4 of 5 decided legs, not all of them
ValuationRCUSValue 10 vs 43
TechnicalsJPMPrice vs 50-day 1.7% vs -22.9%; vs 200-day 6.6% vs -28.8%
Risk ResilienceJPMRisk Resilience 87 vs 42
Analyst expectationsRCUSTarget upside 7.8% vs 161%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of JPM and RCUS and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is wide at 26 points. (supports the conclusion holding)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on JPM.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

JPM lead: Strengthening — the AIQ differential moved from 15 to 26 points over 30 sessions.

May 27JPM leads above the line · RCUS leads belowNov 13
Today
JPM +26
65 vs 39
7 sessions ago
JPM +26
64 vs 38
30 sessions ago
JPM +15
63 vs 48
90 sessions ago
JPM +6
64 vs 58

The lead changed hands 3 times in this window, most recently on Jul 23 when JPM moved ahead of RCUS.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

JPMConflicted

6 bullish / 1 bearish / 1 neutral, conflicted

Only JPM

  • Bollinger Band Squeeze — neutral, volatility, short horizon (5.9%)
  • Golden Cross Active — bullish, trend, long horizon (4.79%)
  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.0%)
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.65x)
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
  • TRIX Bullish Signal — bullish, momentum, short horizon
  • Uptrend Structure Active — bullish, trend, long horizon
RCUS

0 bullish / 3 bearish / 2 neutral

Only RCUS

  • Death Cross Active — bearish, trend, long horizon (8.19%)
  • 52-Week Low Proximity — bearish, risk_regime, long horizon (0.0%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (6.93%)
  • Downtrend Structure Active — bearish, trend, long horizon

JPM leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

JPMNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.98%, AIQ 0 points).

RCUSNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.91%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1RCUS closes the Quality gap — currently 45 points behind, the largest single contributor to JPM's edge.
  2. 2RCUS's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3JPM's conflicting signal state resolves bearish — it currently carries 6 bullish and 1 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

JPM leads on balance
MetricJPMRCUS
Revenue growth (YoY)-7.6%-78%
EPS growth (YoY)-27.6%-38.9%
Gross margin63.2%95%
Operating margin28.2%-4.8%
Return on equity (TTM)4.1%-35.8%
Debt to equity3.320.32

Performance

JPM leads 6 of 6 windows
MetricJPMRCUS
1 week (5 sessions)3.5%-4.6%
1 month (20 sessions)1.9%-21.2%
3 months (63 sessions)-4.1%-41%
6 months (126 sessions)16.2%-26.7%
Year to date7.4%-26.9%
1 year (252 sessions)8%-12.9%

Technicals

JPM has the stronger structure
MetricJPMRCUS
RSI (14)56.135.1
ADX (14)1829.6
Price vs 50-day1.7%-22.9%
Price vs 200-day6.6%-28.8%
Volatility (1M, annualized)27.4%92.2%

Risk

JPM is the more resilient
MetricJPMRCUS
Beta0.781.56
Sharpe ratio0.440.05
Sortino ratio0.610.07
Max drawdown-15.5%-44.8%
Current drawdown-5.2%-44.8%
Annualized volatility22.7%62.7%
Value at risk (95%)-2.4%-6.2%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, JPM or RCUS?

On the Algovestiq AIQ Score, JPM is the stronger of the two as of Nov 15, 2026, scoring 65 against RCUS's 39. The edge comes from quality and risk resilience. RCUS is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is JPM or RCUS the better buy right now?

JPM carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 4 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor JPM over RCUS?

The composite weights Quality, Value, Momentum and Risk Resilience. JPM leads Quality by 45 points; JPM leads Risk Resilience by 45 points; JPM leads Momentum by 36 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, JPM or RCUS?

Analyst price targets imply +7.8% upside for JPM and +161% for RCUS, so the Street currently favors RCUS. That points the opposite way to the AIQ Score, which favors JPM. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, JPM or RCUS?

RCUS is the better-valued of the two on the peer-relative Value factor. RCUS on the peer-relative Value factor, by 33 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, JPM or RCUS?

JPM on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, JPM or RCUS?

JPM on the Momentum factor, by 36 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, JPM or RCUS?

JPM is the more resilient of the two, so the other name carries the higher downside risk. JPM on Risk Resilience, by 45 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is JPM more profitable than RCUS?

The profitability evidence is mixed: gross margin 63.2% vs 95%; operating margin 28.2% vs -4.7%; ttm roe 4.1% vs -35.8%. JPM leads on two measures and RCUS on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is JPM's lead over RCUS getting stronger or weaker?

JPM lead: Strengthening — the AIQ differential moved from 15 to 26 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 3 times in that window, most recently on 2026-07-23, when JPM moved ahead of RCUS.

What would change the JPM vs RCUS verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: RCUS closes the Quality gap — currently 45 points behind, the largest single contributor to JPM's edge; RCUS's Death Cross Active resolves — a bearish trend rule currently active against it; JPM's conflicting signal state resolves bearish — it currently carries 6 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about JPM and RCUS?

JPM: 6 bullish / 1 bearish / 1 neutral, conflicted. RCUS: 0 bullish / 3 bearish / 2 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on JPM is Golden Cross Active (bullish, long horizon). On RCUS it is Death Cross Active (bearish, long horizon).

Compare JPM and RCUS with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.